2023
DOI: 10.1016/j.bulcan.2022.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Nouvelles AMMs : l’axicabtagene ciloleucel (cellules CAR-T) dans les lymphomes diffus à grandes cellules et en deuxième ligne thérapeutique

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 6 publications
0
0
0
Order By: Relevance